1.7200
25-11月-24 16:45:01
15 分の遅延
株式
+0.0200
+1.18%
本日の幅
1.6800 - 1.8100
ISIN
N/A
ソース
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 10 2022 09:00:00 提供 Nasdaq GlobeNewswire